A previous study reported that glioma cells with IDH1 mutation produce 2-hydroxyglutarate, which promotes HIF-1α degradation, accompanied by the downregulation of glycolysis-related genes including SLC2A1, PDK1, LDHA, and SLC16A3 [39]. Here, IDH1 is linked to central nervous system cancer.